QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ubs-maintains-neutral-on-popular-lowers-price-target-to-127

UBS analyst Nicholas Holowko maintains Popular (NASDAQ:BPOP) with a Neutral and lowers the price target from $135 to $127.

 wells-fargo-maintains-overweight-on-popular-lowers-price-target-to-135

Wells Fargo analyst Timur Braziler maintains Popular (NASDAQ:BPOP) with a Overweight and lowers the price target from $150 t...

 popular-q3-eps-314-beats-293-estimate-sales-646505m-miss-671268m-estimate

Popular (NASDAQ:BPOP) reported quarterly earnings of $3.14 per share which beat the analyst consensus estimate of $2.93 by 7.02...

 populars-earnings-outlook
Popular's Earnings Outlook
10/22/2025 17:03:01

 popular-has-first-look-advantage-to-puerto-rican-structural-tailwinds-says-bullish-analyst

Analyst initiates coverage with Buy rating for Popular, citing structural tailwinds supporting Puerto Rico's economy.

 truist-securities-initiates-coverage-on-popular-with-buy-rating-announces-price-target-of-153

Truist Securities analyst Arren Cyganovich initiates coverage on Popular (NASDAQ:BPOP) with a Buy rating and announces Price...

 wells-fargo-maintains-overweight-on-popular-raises-price-target-to-150

Wells Fargo analyst Timur Braziler maintains Popular (NASDAQ:BPOP) with a Overweight and raises the price target from $140 t...

 pe-ratio-insights-for-popular
P/E Ratio Insights for Popular
09/03/2025 21:00:26

 keefe-bruyette--woods-maintains-outperform-on-popular-raises-price-target-to-132

Keefe, Bruyette & Woods analyst Kelly Motta maintains Popular (NASDAQ:BPOP) with a Outperform and raises the price targe...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION